Medicus Pharma Stock Revenue
MDCX Stock | 3.95 0.25 6.76% |
Medicus Pharma fundamentals help investors to digest information that contributes to Medicus Pharma's financial success or failures. It also enables traders to predict the movement of Medicus Stock. The fundamental analysis module provides a way to measure Medicus Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicus Pharma stock.
Last Reported | Projected for Next Year |
Medicus |
Medicus Pharma Company Revenue Analysis
Medicus Pharma's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Medicus
Projected quarterly revenue analysis of Medicus Pharma provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Medicus Pharma match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Medicus Pharma's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Medicus Pharma reported 0.0 of revenue. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Revenue (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Medicus Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicus Pharma's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicus Pharma could also be used in its relative valuation, which is a method of valuing Medicus Pharma by comparing valuation metrics of similar companies.Medicus Pharma is currently under evaluation in revenue category among its peers.
Medicus Fundamentals
Current Valuation | 39.65 M | |||
Shares Outstanding | 11.82 M | |||
Number Of Shares Shorted | 900 | |||
Price To Book | 9.45 X | |||
Net Income | (6.78 M) | |||
Total Debt | 1.09 M | |||
Cash Flow From Operations | (4.16 M) | |||
Short Ratio | 0.96 X | |||
Earnings Per Share | (1.25) X | |||
Target Price | 5.61 | |||
Market Capitalization | 46.68 M | |||
Total Asset | 1.89 M | |||
Retained Earnings | (19.18 M) | |||
Working Capital | 805.8 K | |||
Net Asset | 1.89 M |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.